OQROGet OQRO Pro
Insider trade

Boston Scientific (BSX)CEO sold ~$7.53M

Michael F Mahoney, CEO at Boston Scientific, sold ~$7.53M of Boston Scientific shares.

~$7.53M
Approx. value · 73K sh @ $102.92
1.63M
Holds after · shares reported
Traded
May 1, 2025
Filed
May 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 11, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  2. Feb 13, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  3. Feb 24, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  4. Feb 28, 2025InsiderOfficer sold ~$1M of BSX shares in the open market
  5. Mar 3, 2025InsiderOfficer sold ~$750K of BSX shares in the open market
  6. Mar 3, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  7. Mar 4, 2025InsiderOfficer sold ~$50K of BSX shares in the open market
  8. Mar 17, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  9. Mar 21, 2025InsiderOfficer sold ~$487K of BSX shares in the open market
  10. Apr 1, 2025InsiderCEO sold ~$16.4M of BSX shares in the open market
  11. Apr 21, 2025InsiderOfficer sold ~$459K of BSX shares in the open market
  12. Apr 21, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  13. Apr 28, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  14. May 1, 2025 · this disclosureInsiderCEO sold ~$7.53M of BSX shares in the open market

What came next

  1. May 1, 2025Insider · 2 peopleInsiders: 2 sales (~$11.1M)
  2. May 5, 2025InsiderOfficer sold ~$478K of BSX shares in the open market
  3. May 12, 2025CongressDisclosed sale of BSX — reported range $15,001 - $50,000
  4. May 13, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  5. May 21, 2025InsiderOfficer sold ~$514K of BSX shares in the open market
  6. May 29, 2025InsiderDirector sold ~$418K of BSX shares in the open market
  7. Jun 2, 2025Insider · 1 personInsiders: 2 sales (~$17.1M)
  8. Jun 4, 2025InsiderOfficer sold ~$5.8M of BSX shares in the open market
  9. Jun 11, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  10. Jun 26, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  11. Jul 1, 2025InsiderOfficer sold ~$5.35M of BSX shares in the open market
  12. Jul 25, 2025InsiderDirector sold ~$424K of BSX shares in the open market
  13. Jul 29, 2025InsiderDirector sold ~$310K of BSX shares in the open market
  14. Jul 31, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  15. Aug 1, 2025Insider · 2 peopleInsiders: 2 sales (~$7.0M)
  16. Aug 20, 2025FDARecall: Model Number L231, PROPONENT DR EL MRI Pacemaker
  17. Aug 20, 2025FDARecall: Model Number L211 PROPONENT DR SL MRI Pacemaker
  18. Aug 20, 2025FDARecall: Model Number S702, ALTRUA 2 DR SL Pacemaker
  19. Aug 20, 2025FDARecall: Model Number U128, VALITUDE CRT-P EL MRI
  20. Aug 20, 2025FDARecall: Model Number U125, VALITUDE CRT-P EL
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Michael F Mahoney, Chairman, President & CEO

The full history of Michael F Mahoney, Chairman, President & CEO is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data